WH Brady & Company Board of Directors
Get the latest insights into the leadership at WH Brady & Company. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Pavan G Morarka | Chairman & Managing Director |
| Mr. Vaibhav P Morarka | Non Executive Director |
| Ms. Chitralekha Hiremath | Independent Woman Director |
| Mr. Cyrus Vachha | Independent Director |
| Mr. Pinaki Misra | Independent Director |
| Mr. Ravindra Joshi | Independent Director |
WH Brady & Company Share price
WHBRADY
725.95
5.25 (-0.72%)Last updated on 4 Nov, 2025 | 15:29 IST
BUYSELL
Today's High
731.20
Today's Low
714.00
52 Week Low
650.30
52 Week High
1151.00
The current prices are delayed, login to your account for live prices
LoginWH Brady & Company FAQs
The board at WH Brady & Company consists of experienced professionals, including Mr. Pavan G Morarka , Mr. Vaibhav P Morarka , and others, overseeing the company’s strategic and corporate governance.
Directors at WH Brady & Company are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Pavan G Morarka is the current chairman at WH Brady & Company.
Executive directors at WH Brady & Company are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, WH Brady & Company adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At WH Brady & Company, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.